J9192 HCPCS Level II code: Injection, fluorouracil, 10 mg
J9192 is the HCPCS code for “Injection, fluorouracil, 10 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9192Injection, fluorouracil, 10 mg
Short description: Inj, fluorouracil, 10 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J9192 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Oct 1, 2026
Where J9192 sits
- 1J codesDrugs administered other than orally
- 2Active code J9192Injection, fluorouracil, 10 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9192 mean?
J9192 is the HCPCS code for “Injection, fluorouracil, 10 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9192?
CMS lists J9192’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9192
All J codesJ9184Injection, gemcitabine hydrochloride (avyxa), 200 mgJ9185Injection, fludarabine phosphate, 50 mgJ9186Injection, etoposide (avyxa), 1 mgJ9187Injection, etoposide, 1 mgJ9190Injection, fluorouracil, 500 mgJ9191Injection, fluorouracil (avyxa), 10 mgJ9196Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mgJ9198Injection, gemcitabine hydrochloride, (infugem), 100 mgJ9199Injection, gemcitabine hydrochloride (infugem), 200 mgJ9200Injection, floxuridine, 500 mgJ9201Injection, gemcitabine hydrochloride, not otherwise specified, 200 mgJ9202Goserelin acetate implant, per 3.6 mg